Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 02, 2026 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Commercially Launches Precise MRD with Select Community Oncologists

Myriad Genetics announces the launch of the Precise MRD test with a select number of oncology practices for patients with breast cancer.
February 24, 2026 09:00 ET | Source: Myriad Genetics, Inc.

Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests

Data presented at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests.
February 23, 2026 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution

Myriad Genetics reports fourth quarter and full-year 2025 financial results; reiterates 2026 financial guidance reflecting strengthened execution.